相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics
Amanda M. Casto et al.
BLOOD REVIEWS (2022)
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy
Anna B. Halpern et al.
LEUKEMIA & LYMPHOMA (2022)
Clinical Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA for the Diagnosis of Infectious Diseases: A Multicenter Retrospective Cohort Study
Catherine A. Hogan et al.
CLINICAL INFECTIOUS DISEASES (2021)
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
Muhammad Umair Mushtaq et al.
LEUKEMIA & LYMPHOMA (2021)
Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
Sang-Min Oh et al.
SCIENTIFIC REPORTS (2021)
Early hospital discharge after intensive induction chemotherapy for adults with acute myeloid leukemia or other high-grade myeloid neoplasm
Anna B. Halpern et al.
LEUKEMIA (2020)
Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey
Anke Verlinden et al.
BONE MARROW TRANSPLANTATION (2020)
Randomized phase 1 study of sequential (primed) vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Raffaele Palmieri et al.
LEUKEMIA & LYMPHOMA (2020)
Evaluation of Plasma Microbial Cell-Free DNA Sequencing to Predict Bloodstream Infection in Pediatric Patients With Relapsed or Refractory Cancer
Kathryn P. Goggin et al.
JAMA ONCOLOGY (2020)
Updates in infection risk and management in acute leukemia
C. Logan et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Fungaemia in haematological malignancies: SEIFEM-2015 survey
Marianna Criscuolo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
Anna B. Halpern et al.
HAEMATOLOGICA (2019)
Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia
Marla M. Jalbut et al.
LEUKEMIA & LYMPHOMA (2018)
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms
Anna B. Halpern et al.
LEUKEMIA (2018)
Quality of life from the perspective of the patient with acute myeloid leukemia
Sarah A. Buckley et al.
CANCER (2018)
Association of Risk Factors, Mortality, and Care Costs of Adults With Acute Myeloid Leukemia With Admission to the Intensive Care Unit
Anna B. Halpern et al.
JAMA ONCOLOGY (2017)
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization
Sarah Anand et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
Torsten Dahlen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial
Colleen Delaney et al.
LANCET HAEMATOLOGY (2016)
Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia
Anna B. Halpern et al.
BLOOD (2015)
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes
Sarah A. Buckley et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure
Michael V. Jaglal et al.
LEUKEMIA RESEARCH (2014)
Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial
Giovanna Cannas et al.
LEUKEMIA & LYMPHOMA (2012)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy
S. Gill et al.
ANNALS OF ONCOLOGY (2010)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)
Ewa Lech-Maranda et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group
Agnieszka Wierzbowska et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Bacteraernia in febrile neutropenic cancer patients
J. Klastersky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Infectious complications of purine analog therapy
G Samonis et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2001)
分享论文
